Validation of Controlled Attenuation Parameter Measured by FibroScan As a Novel Surrogate Marker for the Evaluation of Metabolic Derangement.
Frontiers in Endocrinology（2022）
关键词
non-alcoholic fatty liver disease (NAFLD),controlled attenuation parameter (CAP),metabolic syndrome (MetS),diabetes mellitus,insulin resistance,FibroScan
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要